COPPELL, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology and leading innovator of naturally-sourced supplements based on Real Food Technology® solutions, announced that its shareholders passed all proposals put to a vote at the company’s annual shareholder meeting held Wednesday, May 28, 2014.
Mannatech’s Chairman of the Board J. Stanley Fredrick chaired the meeting and Mark Nicholls, Mannatech’s Chief Financial Officer spoke to the shareholders sharing the company’s financial results for 2013 and the first quarter of 2014.
There were 2,654,913 outstanding shares of Mannatech’s common stock as of April 4, 2014 entitled to vote and 1,805,996 shares, or 68.02%, represented at the meeting, either in person or by proxy.
The following matters were submitted and voted upon at the meeting:
1. Mannatech shareholders voted to elect two individuals to the Board of Directors as a Class III Director as set forth below:
| Name | Number of shares For | Number of shares Withheld | Broker Non-Votes | |||||||||
| Alan D. Kennedy | 856,912 | 79,381 | 869,703 | |||||||||
| Robert A. Toth | 858,942 | 77,351 | 869,703 | |||||||||
2. Mannatech shareholders voted to ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2014 as set forth below:
| Number of shares For | Number of shares Against | Number of shares Abstaining | ||||||
| 1,706,583 | 45,977 | 53,436 | ||||||
3. Mannatech shareholders approved, on an advisory basis, the compensation of the company’s named executive officers as set forth below:
| Number of shares For | Number of shares Against | Number of shares Abstaining | Broker Non-Votes | |||||||||
| 921,981 | 9,765 | 4,547 | 869,703 | |||||||||
4. Mannatech shareholders voted to approve an amendment to the 2008 Stock Incentive Plan to increase the number of shares of common stock subject to the plan by 130,000 as set forth below:
| Number of shares For | Number of shares Against | Number of shares Abstaining | Broker Non-Votes | |||||||||
| 855,634 | 77,534 | 3,125 | 869,703 | |||||||||
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales associates around the globe including North America (United States, Canada, and Mexico), Asia/Pacific (Australia, New Zealand, Japan, Taiwan, Singapore, the Republic of Korea, and Hong Kong), and EMEA (Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Estonia, Finland, the Republic of Ireland, Czech Republic, South Africa, and the Republic of Namibia). For more information, visit Mannatech.com.
Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “anticipate,” “believe,” “will,” “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
